---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-012673"
form_type: "8-K"
ticker: "DYAI"
cik: "0001213809"
company_name: "DYADIC INTERNATIONAL INC"
filed_at: "2026-03-25T23:59:59+00:00"
generated_at: "2026-05-15T08:58:24.169365+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Dyadic reports FY 2025 net loss of $7.36M; revenue down to $3.09M

## Summary
- Cash and securities of $8.59M as of Dec 31, 2025, down from $9.29M a year earlier.
- Revenue fell to $3.09M from $3.50M; net loss widened to $7.36M ($0.23/sh) from $5.81M ($0.20/sh).
- Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant; Dyadic eligible for profit share.
- Expanded Fermbox Bio collaboration; commercial launch of recombinant DNase I (RNase-free).
- OEM distribution agreement with IBT Bioservices for DNase I and transferrin; BRIG Bio deal for alpha-lactalbumin.

## SEC filing metadata
- accession: 0001493152-26-012673
- form_type: 8-K
- ticker: DYAI
- cik: 0001213809
- company_name: DYADIC INTERNATIONAL INC
- filed_at: 2026-03-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213809/000149315226012673/0001493152-26-012673-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213809/000149315226012673/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-012673
- JSON: https://secwatch.observer/filing/0001493152-26-012673.json
- Plain text: https://secwatch.observer/filing/0001493152-26-012673.txt

## Key facts
- Earnings Releases
  DYADIC INTERNATIONAL INC reported financial results for the year ended December 31, 2025.
  - Period: the year ended December 31, 2025
  - Result: reported results
  source text: On March 25, 2026, Dyadic International, Inc. (“Dyadic”) issued a press release announcing its results for the year ended December 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1213809/000149315226012673/0001493152-26-012673-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.